Cargando…

Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma

BACKGROUND: Previous metabolomics studies have found differences in metabolic characteristics between the healthy and ESCC patients. However, few of these studies concerned the whole process of the progression of ESCC. This study aims to explore serum metabolites associated with the progression of E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xia, Zhao, Lihong, Wei, Mengke, Lv, Jiali, Sun, Yawen, Shen, Xiaotao, Zhao, Deli, Xue, Fuzhong, Zhang, Tao, Wang, Jialin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100812/ https://www.ncbi.nlm.nih.gov/pubmed/33976728 http://dx.doi.org/10.7150/jca.54429

Ejemplares similares

A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma
por: Lv, Jiali, et al.
Publicado: (2021)

The mediation effect of serum metabolites on the relationship between long-term smoking exposure and esophageal squamous cell carcinoma
por: Wei, Mengke, et al.
Publicado: (2021)

Risk Factors Associated with Precancerous Lesions of Esophageal Squamous Cell Carcinoma: a Screening Study in a High Risk Chinese Population
por: Sun, Yawen, et al.
Publicado: (2019)

Development and Validation of Esophageal Squamous Cell Carcinoma Risk Prediction Models Based on an Endoscopic Screening Program
por: Han, Junming, et al.
Publicado: (2023)

Development and Validation of an Esophageal Squamous Cell Carcinoma Risk Prediction Model for Rural Chinese: Multicenter Cohort Study
por: Han, Junming, et al.
Publicado: (2021)

Progression of precancerous lesions of esophageal squamous cell carcinomas in a high‐risk, rural Chinese population
por: Gao, Dongqing, et al.
Publicado: (2022)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

The long-term spatial-temporal trends and burden of esophageal cancer in one high-risk area: A population-registered study in Feicheng, China
por: Sun, Xiubin, et al.
Publicado: (2017)

Untargeted metabolomics analysis of esophageal squamous cell cancer progression
por: Yang, Tao, et al.
Publicado: (2022)

Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
por: Zhang, Su, et al.
Publicado: (2020)

Characterization of the Oral and Esophageal Microbiota in Esophageal Precancerous Lesions and Squamous Cell Carcinoma
por: Li, Zhengqi, et al.
Publicado: (2021)

Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers
por: Zhu, Zi-Jia, et al.
Publicado: (2020)

Identification of Plasma Metabolomic Profiling for Diagnosis of Esophageal Squamous-Cell Carcinoma Using an UPLC/TOF/MS Platform
por: Liu, Ran, et al.
Publicado: (2013)

Risk factors for precancerous lesions of esophageal squamous cell carcinoma in high-risk areas of rural China: A population-based screening study
por: Lu, Peipei, et al.
Publicado: (2020)

Genetic analysis of rapidly progressing esophageal squamous cell carcinoma: A case report
por: Zhao, Shuang, et al.
Publicado: (2021)

Reciprocal regulation of LINC00941 and SOX2 promotes progression of esophageal squamous cell carcinoma
por: Lu, Jun-Tao, et al.
Publicado: (2023)

DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis
por: Ji, Yan-Mei, et al.
Publicado: (2016)

Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma
por: Li, Minjuan, et al.
Publicado: (2020)

Principle and progress of radical treatment for locally advanced esophageal squamous cell carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2022)

The Prognostic Significance of Metastatic Nodal Size in Non-surgical Patients With Esophageal Squamous Cell Carcinoma
por: Zhao, Zongxing, et al.
Publicado: (2020)

Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients
por: Wang, Xin, et al.
Publicado: (2020)

Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer
por: Liu, Xuejiao, et al.
Publicado: (2023)

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
por: Li, Yan, et al.
Publicado: (2022)

Corrigendum: Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients
por: Wang, Xin, et al.
Publicado: (2021)

Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach
por: Zhang, Yaowen, et al.
Publicado: (2020)

(1)H-NMR spectroscopy identifies potential biomarkers in serum metabolomic signatures for early stage esophageal squamous cell carcinoma
por: Liu, Yan-Yan, et al.
Publicado: (2019)

Dandelion Seed Extract Affects Tumor Progression and Enhances the Sensitivity of Cisplatin in Esophageal Squamous Cell Carcinoma
por: Li, Yuxi, et al.
Publicado: (2022)

USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP
por: Zhang, Wenhao, et al.
Publicado: (2022)

The anthelmintic drug flubendazole induces cell apoptosis and inhibits NF-κB signaling in esophageal squamous cell carcinoma
por: Tao, Jiali, et al.
Publicado: (2019)

SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression
por: Zhang, Xiao, et al.
Publicado: (2020)

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
por: Jiang, Zongdan, et al.
Publicado: (2021)

The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers
por: Ren, Zhenxing, et al.
Publicado: (2021)

Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma
por: Yu, Mengjie, et al.
Publicado: (2022)

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
por: Zhang, Qingyi, et al.
Publicado: (2019)

LncRNA LOXL1-AS1 promotes esophageal squamous cell carcinoma progression by targeting DESC1
por: Li, Hongle, et al.
Publicado: (2021)

Circular RNA circ‐FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA
por: Zhou, Yongjia, et al.
Publicado: (2023)

SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling
por: Zhang, Aijia, et al.
Publicado: (2019)

Identification of Serum MicroRNAs as Novel Biomarkers in Esophageal Squamous Cell Carcinoma Using Feature Selection Algorithms
por: Zheng, Deqiang, et al.
Publicado: (2019)

Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
por: Wang, Xiao-Xia, et al.
Publicado: (2014)

Role of Brg1 in progression of esophageal squamous cell carcinoma
por: Torkamandi, Shahram, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rp98t3f4jd7s7qllug9v6vvu7c